ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)
Japan flag Japan · Delayed Price · Currency is JPY
2,403.00
-30.00 (-1.23%)
Feb 13, 2026, 3:30 PM JST

TYO:4886 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
6,1929,8625,3576,1633,575
Depreciation & Amortization
2,2472,6623,1272,8853,305
Loss (Gain) From Sale of Assets
30026-3,4667
Loss (Gain) From Sale of Investments
-127-3,340-1241,151-491
Loss (Gain) on Equity Investments
534119-18-
Other Operating Activities
-3,938-1,532-854-2,224-226
Change in Accounts Receivable
1,203-370-742-1,361639
Change in Inventory
-2,675-2,713-2,627-687-330
Change in Accounts Payable
3391,494-980412392
Change in Other Net Operating Assets
-1,109-4,620169-13-330
Operating Cash Flow
2,4851,4863,3512,8426,541
Operating Cash Flow Growth
67.23%-55.66%17.91%-56.55%-
Capital Expenditures
-2,960-1,320-461-579-1,104
Sale of Property, Plant & Equipment
-1-10,312-
Cash Acquisitions
-2,189-1,464--53-
Sale (Purchase) of Intangibles
-602-133-285-1,798-
Investment in Securities
7523,778-210-45-1,743
Other Investing Activities
-1,125844-170-1,094-19
Investing Cash Flow
-6,1241,706-1,1266,743-2,866
Long-Term Debt Issued
3,000---77
Total Debt Issued
3,000---77
Short-Term Debt Repaid
----50-100
Long-Term Debt Repaid
-4,680-3,138-1,423-2,298-
Total Debt Repaid
-4,680-3,138-1,423-2,348-100
Net Debt Issued (Repaid)
-1,680-3,138-1,423-2,348-23
Repurchase of Common Stock
-955-24852
Common Dividends Paid
-1,275-792-452-398-484
Other Financing Activities
-1-22--2-
Financing Cash Flow
-2,956-3,943-1,820-2,996-455
Foreign Exchange Rate Adjustments
-97-15-2--
Miscellaneous Cash Flow Adjustments
556--1--1
Net Cash Flow
-6,136-7664026,5893,219
Free Cash Flow
-4751662,8902,2635,437
Free Cash Flow Growth
--94.26%27.71%-58.38%-
Free Cash Flow Margin
-0.74%0.26%4.78%4.00%9.85%
Free Cash Flow Per Share
-16.765.86102.3479.77191.76
Cash Interest Paid
5141515858
Cash Income Tax Paid
4,0261,6118501,385225
Levered Free Cash Flow
-6,5686,9722,067633.54,744
Unlevered Free Cash Flow
-6,5366,9972,098668.54,781
Change in Working Capital
-2,242-6,209-4,180-1,649371
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.